课题基金 / 基金详情

GH16-006: Conducting Communicable Disease Research in Kenya

GH16-006: Conducting Communicable Disease Research in Kenya
GH16-006:在肯尼亚进行传染病研究
批准号:
10002061
负责人:
M KARIUKI NJENGA
金额:
$353.98万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-30 至 2021-09-29

项目摘要

项目成果

M KARIUKI NJENGA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Washington State University (WSU) proposes research in Kenya to address 7 objectives in Component A, Communicable Disease, of RFA-GH-16-006. The research is organized into three projects that together address the following objectives: Project 1 (i) develop, maintain and expand surveillance systems combining population-based and facility-based demographic, morbidity and mortality surveillance; (ii) develop laboratory capacity and platforms for etiologic investigation and evaluation of novel diagnostic; Project 2 (iii) conduct studies to assess the disease burden, risk factors, and prevention of zoonotic infections; (iv) conduct surveillance and research on antimicrobial resistance; (v) conduct research on the epidemiology and ecology of arboviruses and their vectors; and Project 3 (vi) conduct socio-cultural research on knowledge, attitudes and practice related to infectious disease and acceptance of prevention methods; (vii) develop cost of disease and intervention estimates. To accomplish these objectives, WSU has assembled a team of 20 scientists derived from WSU, University of Nairobi (UON), Emory University, Kenya Medical Research Institute (KEMRI), Kansas State University, and the government of Kenya. In addition, we have enlisted the infrastructural support of KEMRI, UON, and Henry Jackson Foundation. Since 2001, CDC has managed the human demographic surveillance system, rural and urban population-based infectious disease surveillance in Kenya. These platforms and the supporting laboratories were designed to assist in determining the burden of diseases and in conducting disease intervention trials. Here, WSU proposes to start by managing the platforms as-is, but also pilot new approaches to promote their fiscal sustainability. Through the platforms and other surveillance approaches, WSU will investigate the burden and risk factors of endemic and emerging diseases and antimicrobial resistance. In addition, we will conduct intervention studies to address the threats, and engage the government of Kenya to share data and advocate for policy change. Social scientists will work with the disease research team to assess the perceptions of diseases and treatment options, as well as behaviors that may affect human-human and animal-human transmission. To assess the economic burden of disease and cost-effectiveness of interventions, both direct and indirect impacts will be considered. The outcome of this project will be better understanding of level of these threats, and development of interventions that result in improvement of the health of Kenyans and reduction in global health threats.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GH21-003, Advancing Public Health Research in Kenya
  • 批准号:
    10893917
  • 项目类别:
  • 资助金额:
    $55.57万
  • 财政年份:
    2021
  • 负责人:
    M KARIUKI NJENGA
  • 依托单位:
Emerging Infectious Diseases Research Center - East and Central Africa
  • 批准号:
    10464357
  • 项目类别:
  • 资助金额:
    $66.45万
  • 财政年份:
    2021
  • 负责人:
    M KARIUKI NJENGA
  • 依托单位:
GH21-003, Advancing Public Health Research in Kenya
  • 批准号:
    10630848
  • 项目类别:
  • 资助金额:
    $12.0万
  • 财政年份:
    2021
  • 负责人:
    M KARIUKI NJENGA
  • 依托单位:
GH21-003, Advancing Public Health Research in Kenya
  • 批准号:
    10472398
  • 项目类别:
  • 资助金额:
    $742.7万
  • 财政年份:
    2021
  • 负责人:
    M KARIUKI NJENGA
  • 依托单位:
国内基金
海外基金
评价呼吸道合胞病毒二价mRNA疫苗(IN006)在60周岁及以上健康人群安全性和免疫原性的临床研究
  • 批准号:
    2026JJ82041
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    赵俊仕
  • 依托单位:
新型抗帕金森病候选药物T-006调控线粒体抑制小胶质细胞NLRP3炎性小体激活机理研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    陈海云
  • 依托单位:
MEF2激活剂T-006对阿尔茨海默病的神经保护作用及机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    55万元
  • 批准年份:
    2021
  • 负责人:
    杨细飞
  • 依托单位:
死亡受体5靶向分子探针89Zr-CTB006的构建及其在PET免疫显像中的研究
  • 批准号:
    82102091
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    王淑静
  • 依托单位: